465 related articles for article (PubMed ID: 20303156)
1. Overcoming the barriers to HPV vaccination in high-risk populations in the US.
Downs LS; Scarinci I; Einstein MH; Collins Y; Flowers L
Gynecol Oncol; 2010 Jun; 117(3):486-90. PubMed ID: 20303156
[TBL] [Abstract][Full Text] [Related]
2. What is the role of HPV typing in the United States now and in the next five years in a vaccinated population?
Huh W; Einstein MH; Herzog TJ; Franco EL
Gynecol Oncol; 2010 Jun; 117(3):481-5. PubMed ID: 20417957
[TBL] [Abstract][Full Text] [Related]
3. Parental acceptance of human papillomavirus (HPV) vaccination in Indonesia: a cross-sectional study.
Jaspers L; Budiningsih S; Wolterbeek R; Henderson FC; Peters AA
Vaccine; 2011 Oct; 29(44):7785-93. PubMed ID: 21821079
[TBL] [Abstract][Full Text] [Related]
4. Human papilloma virus (HPV) prophylactic vaccination: challenges for public health and implications for screening.
Adams M; Jasani B; Fiander A
Vaccine; 2007 Apr; 25(16):3007-13. PubMed ID: 17292517
[TBL] [Abstract][Full Text] [Related]
5. Knowledge and attitudes of adult peruvian women vis-à-vis Human Papillomavirus (HPV), cervical cancer, and the HPV vaccine.
Lee FH; Paz-Soldan VA; Carcamo C; Garcia PJ
J Low Genit Tract Dis; 2010 Apr; 14(2):113-7. PubMed ID: 20354419
[TBL] [Abstract][Full Text] [Related]
6. Programmatic issues in the implementation of an HPV vaccination program to prevent cervical cancer.
Ault K; Reisinger K
Int J Infect Dis; 2007 Nov; 11 Suppl 2():S26-8. PubMed ID: 18162242
[TBL] [Abstract][Full Text] [Related]
7. Recommendations for cervical cancer prevention in Asia Pacific.
Garland SM; Cuzick J; Domingo EJ; Goldie SJ; Kim YT; Konno R; Parkin DM; Qiao YL; Sankaranarayanan R; Stern PL; Tay SK; Bosch FX
Vaccine; 2008 Aug; 26 Suppl 12():M89-98. PubMed ID: 18945418
[TBL] [Abstract][Full Text] [Related]
8. [Vaccination against human papillomavirus for the prevention of cervical cancer].
Quint WG; ter Harmsel WA; van Doorn LJ
Ned Tijdschr Geneeskd; 2006 Jun; 150(25):1380-4. PubMed ID: 16841585
[TBL] [Abstract][Full Text] [Related]
9. Public health issues related to HPV vaccination.
Hershey JH; Velez LF
J Public Health Manag Pract; 2009; 15(5):384-92. PubMed ID: 19704306
[TBL] [Abstract][Full Text] [Related]
10. Human papillomavirus infection and cervical cancer prevention in India, Bangladesh, Sri Lanka and Nepal.
Sankaranarayanan R; Bhatla N; Gravitt PE; Basu P; Esmy PO; Ashrafunnessa KS; Ariyaratne Y; Shah A; Nene BM
Vaccine; 2008 Aug; 26 Suppl 12():M43-52. PubMed ID: 18945413
[TBL] [Abstract][Full Text] [Related]
11. Singaporean men's knowledge of cervical cancer and human papillomavirus (HPV) and their attitudes towards HPV vaccination.
Pitts M; Smith A; Croy S; Lyons A; Ryall R; Garland S; Wong ML; Hseon TE
Vaccine; 2009 May; 27(22):2989-93. PubMed ID: 19428910
[TBL] [Abstract][Full Text] [Related]
12. [Impact of vaccination against oncogenic human papillomavirus on the incidence and mortality of cervical cancer in Germany].
Schneider A; Schwarz TF; Hammerschmidt T; Siebert U
Med Klin (Munich); 2007 Jul; 102(7):515-23. PubMed ID: 17634869
[TBL] [Abstract][Full Text] [Related]
13. [Cervical cancer prevention: the impact of HPV vaccination].
Monsonégo J
Gynecol Obstet Fertil; 2006 Mar; 34(3):189-201. PubMed ID: 16529969
[TBL] [Abstract][Full Text] [Related]
14. Epidemiology of human papillomavirus infection and cervical cancer and future perspectives in Hong Kong, Singapore and Taiwan.
Tay SK; Ngan HY; Chu TY; Cheung AN; Tay EH
Vaccine; 2008 Aug; 26 Suppl 12():M60-70. PubMed ID: 18945415
[TBL] [Abstract][Full Text] [Related]
15. A qualitative analysis of South African women's knowledge, attitudes, and beliefs about HPV and cervical cancer prevention, vaccine awareness and acceptance, and maternal-child communication about sexual health.
Francis SA; Battle-Fisher M; Liverpool J; Hipple L; Mosavel M; Soogun S; Mofammere N
Vaccine; 2011 Nov; 29(47):8760-5. PubMed ID: 21855591
[TBL] [Abstract][Full Text] [Related]
16. Initial lessons learned in HPV vaccination.
Herzog TJ; Huh WK; Downs LS; Smith JS; Monk BJ
Gynecol Oncol; 2008 May; 109(2 Suppl):S4-11. PubMed ID: 18482557
[TBL] [Abstract][Full Text] [Related]
17. Human papillomavirus vaccine acceptability among young adult men.
Gerend MA; Barley J
Sex Transm Dis; 2009 Jan; 36(1):58-62. PubMed ID: 18830138
[TBL] [Abstract][Full Text] [Related]
18. Epidemiology of HPV 16 and cervical cancer in Finland and the potential impact of vaccination: mathematical modelling analyses.
Barnabas RV; Laukkanen P; Koskela P; Kontula O; Lehtinen M; Garnett GP
PLoS Med; 2006 May; 3(5):e138. PubMed ID: 16573364
[TBL] [Abstract][Full Text] [Related]
19. Preventing cervical cancer through human papillomavirus vaccination: perspective from focus groups.
Wong LP
J Low Genit Tract Dis; 2009 Apr; 13(2):85-93. PubMed ID: 19387128
[TBL] [Abstract][Full Text] [Related]
20. Difficulties in the prevention of cervical cancer: adults' attitudes towards HPV vaccination 3 years after introducing the vaccine in Hungary.
Marek E; Dergez T; Kricskovics A; Kovacs K; Rebek-Nagy G; Gocze K; Kiss I; Ember I; Gocze P
Vaccine; 2011 Jul; 29(32):5122-9. PubMed ID: 21624417
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
